IFNGR1 and neoplasm: IFN-γ has been shown to exert potent anti-tumor activity both in vitro and in vivo[32], and deficiencies in IFN-γ (IFN-γ-/-) or the IFN-γ receptor (IFN-γR-/-) accelerated tumor development in mice [33].